Optimizing Strategies for Topical Management of Glaucoma: Treatment Options and Improving Adherence

Release Date: February 1, 2018
Last Reviewed: January 31, 2018
Expiration Date: February 1, 2019
Time to Complete Activity: 1.0 hour
*This activity expired for credit on February 1, 2019 and is no longer available for credit
This activity is provided by Paradigm Medical Communications, LLC.

Anne L. Coleman, MD, PhD (Chair)
Vice Chair
Department of Ophthalmology
Fran and Ray Stark Foundation Professor of Ophthalmology
Stein Eye Institute
David Geffen School of Medicine
Professor of Epidemiology
Fielding School of Public Health
University of California Los Angeles
Stein Eye Institute Center for Community Outreach and Policy
Los Angeles, CA
Gregory J. Katz, MD
Director of Glaucoma Services
St. Joseph Mercy Medical Center
Ann Arbor, MI
L. Jay Katz, MD, FACS
Professor of Ophthalmology
Jefferson Medical College
Attending Surgeon and Director
Glaucoma Service
Wills Eye Hospital
Philadelphia, PA

Patient Faculty
Eleanor Banyai
Detroit, MI
Target Audience
This activity has been designed to meet the educational needs of ophthalmologists.  It will also be of benefit to other healthcare professionals interested in the management of glaucoma.
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
 • Select an appropriate personalized ocular antihypertensive strategy for patients with glaucoma based on the most recent efficacy and safety data related to available agents.
 • Evaluate efficacy and safety data for new and emerging medical treatments in glaucoma.
 • Outline effective strategies to promote patient adherence and self-administration to prescribed glaucoma treatment, including multi-drop and combination regimens.

Table of Contents
• Introduction
• Individualizing Therapy with Current Medical Treatments: Cases and Choices
• Case Study 1
• Case Study 2
• The Case for Emerging Medical Treatments
• Facilitating Patient Adherence and Self-Administration

Physician Accreditation Statement
Paradigm Medical Communications, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Commercial Support
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
Instructions for Participation
To receive a CME certificate of participation, you should:
• Follow instructions to register or log in with your professional information and complete the pretest.
• View the online activity in its entirety.
• Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.
• A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
There is no fee required for participation in this activity.
Hardware/Software Requirements
This certified CME activity is designed using HTML5 video and audio.
Supported Browsers:
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher

For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com

In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Anne L. Coleman, MD, PhD (Chair)
Consultant: Graybug Vision, Inc., Novartis Pharmaceuticals Corporation
Legal Consultant: Glaukos Corporation

Gregory J. Katz, MD
Grant/Research Support: Allergan plc, Novartis Pharmaceuticals Corporation
Consultant: Aerie Pharmaceuticals
Speakers Bureau: Novartis Pharmaceuticals Corporation

L. Jay Katz, MD, FACS
No financial relationships to disclose

Eleanor Banyai
No financial relationships to disclose

Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.

Independent peer reviewer has no financial relationships to disclose.

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC, has implemented a system to resolve conflicts of interest for each CME activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.

This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC, activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.

Terms of Use and Privacy Policy
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.

Privacy policy
Paradigm Medical Communications, LLC, is committed to protecting the privacy of those who participate in the activities (herein referred to as “website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC, to continuously improve the learning experience.
Paradigm Medical Communications, LLC, does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC, will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC, staff members review individual test results to the extent necessary to record and track participants’ credits.

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
© 2018 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.